Sterically stabilized liposomes as a carrier for α-emitting radium and actinium radionuclides

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Nuclear Medicine and Biology

• Publication date

  2004-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NUCMEDBIO.2003.11.004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative autoradiographic evaluation of the influence of protein dose on monoclonal antibody distribution in human ovarian adenocarcinoma xenografts

  2005cited by this paper
• Tumor uptake of 67Ga-carrying liposomes

  2004cited by this paper
• Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice.

  2003cited by this paper
• Evaluation of potential chelating agents for radium.

  2002cited by this paper
• Renaissance of 224Ra for the treatment of ankylosing spondylitis: clinical experiences

  2002cited by this paper
• Design and synthesis of 225Ac radioimmunopharmaceuticals.

  2002cited by this paper
• Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.

  2001cited by this paper
• 223Ra for endoradiotherapeutic applications prepared from an immobilized 227Ac/227Th source

  2001cited by this paper
• Synthesis, conjugation, and radiolabeling of a novel bifunctional chelating agent for (225)Ac radioimmunotherapy applications.

  2000cited by this paper
• Tissue dosimetry of liposome-radionuclide complexes for internal radiotherapy: toward liposome-targeted therapeutic radiopharmaceuticals.

  2000cited by this paper
• Evaluation of 225Ac for Vascular Targeted Radioimmunotherapy of Lung Tumors

  2000cited by this paper
• LIPOSOMES AS CARRIERS OF RADIONUCLIDES: FROM IMAGING TO THERAPY

  1999cited by this paper
• Comparison of dynamic and integrated light-scattering techniques in the study of the interaction of Candida rugosa lipase with DPPC liposomes.

  1999cited by this paper
• Improved in vivo stability of actinium-225 macrocyclic complexes.

  1999cited by this paper
• Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.

  1999cited by this paper
• Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.

  1999cited by this paper
• Monofunctionalization of Calix[4]arene Tetracarboxylic Acid at the Upper Rim with Isothiocyanate Group: First Bifunctional Chelating Agent for Alpha-Emitter Ac-225

  1999cited by this paper
• Comparison of 225actinium chelates: tissue distribution and radiotoxicity.

  1999cited by this paper
• Conjugation, immunoreactivity, and immunogenicity of calix[4]arenes; model study to potential calix[4]arene-based Ac3+ chelators.

  1999cited by this paper
• Immunoliposomes for the targeted delivery of antitumor drugs.

  1999cited by this paper
• Diplasmenylcholine−Folate Liposomes: An Efficient Vehicle for Intracellular Drug Delivery†

  1998cited by this paper
• Carboxylate-derived calixarenes with high selectivity for actinium-225

  1998cited by this paper
• Folate-mediated targeting of therapeutic and imaging agents to cancers.

  1998cited by this paper
• Radioimmunotherapy with alpha-emitting nuclides

  1998cited by this paper
• Gamma emitting radiotracers 224Ra, 212Pb and 212Bi from natural thorium

  1998cited by this paper
• The cytotoxicity and microdosimetry of astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro.

  1998cited by this paper
• Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

  1997cited by this paper
• The design and development of DaunoXome® for solid tumor targeting in vivo

  1997cited by this paper
• Alpha-Emitters for Medical Therapy: Workshop of the United States Department of Energy: Denver, Colorado, May 30-31, 1996

  1997cited by this paper
• Therapeutic opportunities for targeted liposomal drug delivery

  1996cited by this paper
• Long-circulating, polyethylene glycol-grafted immunoliposomes

  1996cited by this paper
• Radiolysis of radioimmunoconjugates. Reduction in antigen-binding ability by α-particle radiation

  1995cited by this paper
• Pharmacokinetics of long-circulating liposomes

  1995cited by this paper
• Potential for improvement in clinical decision-making: tumor imaging with in-111 labeled liposomes results of a phase ii-iii study

  1994cited by this paper
• Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.

  1994cited by this paper
• Barriers to drug delivery in solid tumors.

  1994cited by this paper
• Microdosimetric concepts in radioimmunotherapy.

  1993cited by this paper
• Small-volume extrusion apparatus for preparation of large, unilamellar vesicles.

  1991cited by this paper
• Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles.

  1991cited by this paper
• An improved method for the preparation of liposomal gadolinium-DTPA. Ionophore-mediated active entrapment of gadolinium.

  1991cited by this paper
• A novel method for the efficient entrapment of calcium in large unilamellar phospholipid vesicles.

  1990cited by this paper
• Successful imaging of human cancer with indium‐111‐labeled phospholipid vesicles

  1988cited by this paper
• Dosimetric aspects of radiolabeled antibodies for tumor therapy.

  1986cited by this paper
• Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice.

  1983cited by this paper
• Preparation of lipid vesicles containing high levels of entrapped radioactive cations.

  1979cited by this paper
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

  1978cited by this paper
• High-LET radiations induce a large proportion of non-rejoining DNA breaks

  1977cited by this paper
• Photon correlation study of polydisperse samples of polystyrene in cyclohexane

  1975cited by this paper
• Pepsin digestion of human G-myeloma proteins of different subclasses. I. The characteristic features of pepsin cleavage as a function of time.

  1970cited by this paper
• Phosphorus assay in column chromatography.

  1959cited by this paper

• Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results

  2024cites this paper
• Development of 225Ac-doped biocompatible nanoparticles for targeted alpha therapy

  2024cites this paper
• Methods for Radiolabeling Nanoparticles (Part 3): Therapeutic Use

  2023cites this paper
• Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review

  2023cites this paper
• Review Artikel: Liposom Sebagai Sistem Penghantar Obat Epilepsi Melalui Jalur Intranasal

  2023cites this paper
• The Curies’ element: state of the art and perspectives on the use of radium in nuclear medicine

  2023cites this paper
• Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology

  2022cites this paper
• Delivery of radioimmunotherapy for solid tumors

  2022cites this paper
• Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter 213Bi

  2022cites this paper
• Obstacles and Recommendations for Clinical Translation of Nanoparticle System-Based Targeted Alpha-Particle Therapy

  2021cites this paper
• Improved Formulation of 224Ra-Labeled Calcium Carbonate Microparticles by Surface Layer Encapsulation and Addition of EDTMP

  2021cites this paper
• Nanotargeted radiopharmaceuticals for cancer theranostics

  2021cites this paper
• Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy—Part II. Toxicity, Pharmacokinetics and Biodistribution

  2021cites this paper
• Radiochemical separation of 224Ra from 232U and 228Th sources for 224Ra/212Pb/212Bi generator.

  2021cites this paper
• Nanoradiopharmaceuticals Based on Alpha Emitters: Recent Developments for Medical Applications

  2021cites this paper
• Targeted Radionuclide Therapy of Prostate Cancer—From Basic Research to Clinical Perspectives

  2020cites this paper
• Encapsulation and retention of 225Ac, 223Ra, 227Th, and decay daughters in zircon-type gadolinium vanadate nanoparticles

  2020cites this paper
• Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy

  2020cites this paper
• Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy–Part I

  2020cites this paper
• Nanoparticles in Targeted Alpha Therapy

  2020influential citation
• Quantitative encapsulation and retention of 227Th and decay daughters in core-shell lanthanum phosphate nanoparticles.

  2020cites this paper
• Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer

  2020cites this paper
• A 224Ra-labeled polyoxopalladate as a putative radiopharmaceutical.

  2019cites this paper
• Radiolabeled PET/MRI Nanoparticles for Tumor Imaging

  2019cites this paper
• Facile preparation of radium-doped, functionalized nanoparticles as carriers for targeted alpha therapy

  2019cites this paper
• Radiochemical aspects of alpha emitting radionuclides for medical application

  2019cites this paper
• Current outlook on radionuclide delivery systems: from design consideration to translation into clinics

  2019cites this paper
• Dynamics of Sorption—Desorption of 223Ra Therapeutic α-Emitter on Granulated Hydroxyapatite

  2019cites this paper
• Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials

  2019cites this paper
• Radiopharmaceutical enhancement by drug delivery systems: A review

  2018cites this paper
• Coupling a gamma-ray detector with asymmetrical flow field flow fractionation (AF4): Application to a drug-delivery system for alpha-therapy.

  2018cites this paper
• Ra‐224 labeling of calcium carbonate microparticles for internal α‐therapy: Preparation, stability, and biodistribution in mice

  2018cites this paper
• Multifunctional GdVO4:Eu core-shell nanoparticles containing 225Ac for targeted alpha therapy and molecular imaging.

  2018cites this paper
• LANTHANIDE-BASED CORE-SHELL NANOPARTICLES AS MULTIFUNCTIONAL PLATFORMS FOR TARGETED RADIONUCLIDE THERAPY AND MULTIMODAL MOLECULAR IMAGING

  2018influential citation
• Targeted and Nontargeted α-Particle Therapies.

  2018cites this paper
• A random walk approach to estimate the confinement of α-particle emitters in nanoparticles for targeted radionuclide therapy

  2018cites this paper
• Radiopharmaceuticals Based on Alpha Emitters: Preparation, Properties, and Application

  2018cites this paper
• Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches

  2018cites this paper
• Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.

  2017cites this paper
• Hydroxyapatite particles as carriers for 223Ra

  2017cites this paper
• Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy

  2017cites this paper
• Nanozeolite bioconjugates labeled with 223Ra for targeted alpha therapy.

  2017cites this paper
• Hematopoietic Cell Transplants: Concepts, Controversies, and Future Directions

  2017cites this paper
• Availability of Alpha-Emitting Radioisotopes by Reactor and Accelerator Production and via Decay of Naturally Occurring Parents

  2016cites this paper
• Preliminary Therapy Evaluation of 225Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from 225Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization

  2016cites this paper
• Development of separation technology for the removal of radium-223 from decayed thorium-227 in drug formulations. Material screening and method development

  2016cites this paper
• A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules.

  2016cites this paper
• Radioimmunotherapy and Hematopoietic Cell Transplantation

  2016cites this paper
• Recovery of Ra-223 from natural thorium irradiated by protons

  2016cites this paper
• Synthesis and Applications of Alpha/Beta Emitter-Labelled Nanoparticles

  2016cites this paper
• Synthesis and characterization of lanthanum phosphate nanoparticles as carriers for (223)Ra and (225)Ra for targeted alpha therapy.

  2015cites this paper
• Nanotargeted Radiopharmaceuticals for Nuclear Imaging and Radiotherapy

  2014cites this paper
• Recent advances in nanoparticle-based nuclear imaging of cancers.

  2014cites this paper
• Branched amphiphilic peptide capsules: cellular uptake and retention of encapsulated solutes.

  2014cites this paper
• Radioimmunotherapy with α-particle-emitting radionuclides.

  2014cites this paper
• Retention studies of recoiling daughter nuclides of 225Ac in polymer vesicles.

  2014cites this paper
• Prospects in Folate Receptor-Targeted Radionuclide Therapy

  2013cites this paper
• Functionalized NaA nanozeolites labeled with 224,225Ra for targeted alpha therapy

  2013cites this paper
• Radionuclide Therapy of Leukemias

  2013cites this paper
• Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics.

  2013cites this paper
• Perspectives and potential applications of nanomedicine in breast and prostate cancer

  2013cites this paper
• Targeted radionuclide therapy--an overview.

  2013cites this paper
• Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles

  2012cites this paper
• Liposome imaging agents in personalized medicine.

  2012cites this paper
• Folate-linked drugs for the treatment of cancer and inflammatory diseases.

  2012cites this paper
• Nanomaterials for Radiation Therapy

  2011cites this paper
• In vivo 212Pb/212Bi generator using indium-DTPA-tagged liposomes

  2011cites this paper
• Applications of 211At and 223Ra in targeted alpha-particle radiotherapy.

  2011cites this paper
• Separation of lanthanum, hafnium, barium and radiotracers yttrium-88 and barium-133 using crystalline zirconium phosphate and phosphonate compounds as prospective materials for a Ra-223 radioisotope generator.

  2011cites this paper
• Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells.

  2010cites this paper
• The Scandinavian Sarcoma Group

  2009cites this paper
• Molecular imaging and therapy of cancer with radiolabeled nanoparticles.

  2009cites this paper
• 225Ac Metallofullerene: Toward 225Ac Nanogenerator in Fullerene

  2009cites this paper
• Targeted High-LET Therapy of Bone Metastases

  2008cites this paper
• Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications.

  2008cites this paper
• Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.

  2008cites this paper
• Radionuclide carriers for targeting of cancer

  2008cites this paper
• Alpha-emitting Radioisotopes Production for Radioimmunotherapy

  2007cites this paper
• Internal radiotherapy and dosimetric study for 111In/177Lu-pegylated liposomes conjugates in tumor-bearing mice

  2006cites this paper
• First in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agent.

  2006cites this paper
• High-Activity Radio-Iodine Labeling of Conventional and Stealth Liposomes

  2006cites this paper
• Etude de faisabilité du radiomarquage et du préciblage de liposomes pour la radioimmunothérapie

  2005cites this paper
• Folate receptor-mediated drug targeting: from therapeutics to diagnostics.

  2005cites this paper
• Cancer radioimmunotherapy with alpha-emitting nuclides

  2005cites this paper